|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 493/22 | |
| A61P 35/02 | |||
| A61K 31/122 |
| (11) | Number of the document | 3237066 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15874308.8 |
| Date of filing the European patent application | 2015-12-22 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/067399 |
| Date | 2015-12-22 |
| (87) | Number | WO 2016/106326 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 201462095850 P | 2014-12-23 | US |
| (72) |
KUNNARI, Tero, DE
|
| (73) |
Sloan-Kettering Institute for Cancer Research,
1275 York Avenue, New York, NY 10065,
US
|
| (54) | POLYMORPH OF GRANATICIN B |
| POLYMORPH OF GRANATICIN B |